Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Uin Gan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Discovery Medicine|January 20, 2007
Gene therapy for hemophilia AShu Uin Gan, Roy Y Calne
Expert Opinion on Biological Therapy|September 23, 2006
Genetic engineering for haemophilia AShu Uin Gan, Oi Lian Kon, Roy Y Calne
Nature Reviews. Endocrinology|February 23, 2010
Stem cell and gene therapies for diabetes mellitusRoy Y Calne, Shu Uin Gan, Kok Onn Lee
Frontiers in Immunology|November 26, 2020
Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 LigandHiu Yi Wong, Ankshita Prasad, Shu Uin Gan, et al.
Tissue Engineering. Part A|November 14, 2009
Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivoEliana C Martinez, Jing Wang, Shu Uin Gan, et al.
Stem Cell Research|July 5, 2020
Tissues derived from reprogrammed Wharton's jelly stem cells of the umbilical cord as a platform to study gestational diabetes mellitusChiou Mee Kong, Subramanian Arjunan, Shu Uin Gan, et al.
Biofabrication|June 30, 2020
Fabrication of vascularized tissue constructs under chemically defined culture conditionsGopu Sriram, Harish K Handral, Shu Uin Gan, et al.
The Journal of Gene Medicine|December 29, 2018
Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetesShu Uin Gan, Zhenying Fu, Kian Chuan Sia, et al.
Stem Cell Research & Therapy|February 23, 2020
Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned mediumSubramanian Arjunan, Shu Uin Gan, Mahesh Choolani, et al.
Cardiovascular Research|July 16, 2020
Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarctionZhonghao Tao, Szejie Loo, Liping Su, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Discovery Medicine|January 20, 2007
Gene therapy for hemophilia AShu Uin Gan, Roy Y Calne
Expert Opinion on Biological Therapy|September 23, 2006
Genetic engineering for haemophilia AShu Uin Gan, Oi Lian Kon, Roy Y Calne
Nature Reviews. Endocrinology|February 23, 2010
Stem cell and gene therapies for diabetes mellitusRoy Y Calne, Shu Uin Gan, Kok Onn Lee
Frontiers in Immunology|November 26, 2020
Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 LigandHiu Yi Wong, Ankshita Prasad, Shu Uin Gan, et al.
Tissue Engineering. Part A|November 14, 2009
Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivoEliana C Martinez, Jing Wang, Shu Uin Gan, et al.
Stem Cell Research|July 5, 2020
Tissues derived from reprogrammed Wharton's jelly stem cells of the umbilical cord as a platform to study gestational diabetes mellitusChiou Mee Kong, Subramanian Arjunan, Shu Uin Gan, et al.
Biofabrication|June 30, 2020
Fabrication of vascularized tissue constructs under chemically defined culture conditionsGopu Sriram, Harish K Handral, Shu Uin Gan, et al.
The Journal of Gene Medicine|December 29, 2018
Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetesShu Uin Gan, Zhenying Fu, Kian Chuan Sia, et al.
Stem Cell Research & Therapy|February 23, 2020
Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned mediumSubramanian Arjunan, Shu Uin Gan, Mahesh Choolani, et al.
Cardiovascular Research|July 16, 2020
Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarctionZhonghao Tao, Szejie Loo, Liping Su, et al.
Pageof 3